Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

The mucosal vaccine quandary: intranasal vs. sublingual immunization against influenza.

Pedersen G, Cox R.

Hum Vaccin Immunother. 2012 May;8(5):689-93. doi: 10.4161/hv.19568. Epub 2012 May 1. Review.

PMID:
22495121
[PubMed - indexed for MEDLINE]
2.

Proteosome-adjuvanted intranasal influenza vaccines: advantages, progress and future considerations.

Burt D, Mallett C, Plante M, Zimmermann J, Torossian K, Fries L.

Expert Rev Vaccines. 2011 Mar;10(3):365-75. doi: 10.1586/erv.10.172. Review.

PMID:
21434804
[PubMed - indexed for MEDLINE]
3.

Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization.

Wu Y, Wei W, Zhou M, Wang Y, Wu J, Ma G, Su Z.

Biomaterials. 2012 Mar;33(7):2351-60. doi: 10.1016/j.biomaterials.2011.11.068. Epub 2011 Dec 20.

PMID:
22192540
[PubMed - indexed for MEDLINE]
4.

Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.

de Haan A, Haijema BJ, Voorn P, Meijerhof T, van Roosmalen ML, Leenhouts K.

Vaccine. 2012 Jul 6;30(32):4884-91. doi: 10.1016/j.vaccine.2012.04.032. Epub 2012 Apr 23.

PMID:
22537989
[PubMed - indexed for MEDLINE]
5.

A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.

Joseph A, Itskovitz-Cooper N, Samira S, Flasterstein O, Eliyahu H, Simberg D, Goldwaser I, Barenholz Y, Kedar E.

Vaccine. 2006 May 1;24(18):3990-4006. Epub 2005 Dec 27.

PMID:
16516356
[PubMed - indexed for MEDLINE]
6.

Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.

Hong SH, Byun YH, Nguyen CT, Kim SY, Seong BL, Park S, Woo GJ, Yoon Y, Koh JT, Fujihashi K, Rhee JH, Lee SE.

Vaccine. 2012 Jan 5;30(2):466-74. doi: 10.1016/j.vaccine.2011.10.058. Epub 2011 Oct 31.

PMID:
22051136
[PubMed - indexed for MEDLINE]
7.

Sublingual vaccination with influenza virus protects mice against lethal viral infection.

Song JH, Nguyen HH, Cuburu N, Horimoto T, Ko SY, Park SH, Czerkinsky C, Kweon MN.

Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1644-9. doi: 10.1073/pnas.0708684105. Epub 2008 Jan 28.

PMID:
18227512
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

An open-label comparison of the immunogenicity and tolerability of intranasal and intramuscular formulations of virosomal influenza vaccine in healthy adults.

de B, Zanasi A, Ragusa S, Glück R, Herzog C.

Clin Ther. 2002 Jan;24(1):100-11.

PMID:
11833825
[PubMed - indexed for MEDLINE]
9.

Influenza virus vaccination of patients with chronic lung disease.

Gorse GJ, Otto EE, Daughaday CC, Newman FK, Eickhoff CS, Powers DC, Lusk RH.

Chest. 1997 Nov 5;112(5):1221-33.

PMID:
9367461
[PubMed - indexed for MEDLINE]
10.

Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.

[No authors listed]

Drugs R D. 2003;4(5):312-9. Review.

PMID:
12952502
[PubMed - indexed for MEDLINE]
11.

Influenza vaccines in children.

Neuzil KM, Edwards KM.

Semin Pediatr Infect Dis. 2002 Jul;13(3):174-81. Review.

PMID:
12199613
[PubMed - indexed for MEDLINE]
12.

Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.

Hagenaars N, Mastrobattista E, Glansbeek H, Heldens J, van den Bosch H, Schijns V, Betbeder D, Vromans H, Jiskoot W.

Vaccine. 2008 Dec 2;26(51):6555-63. doi: 10.1016/j.vaccine.2008.09.057.

PMID:
18848856
[PubMed - indexed for MEDLINE]
13.

Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity.

Bakke H, Samdal HH, Holst J, Oftung F, Haugen IL, Kristoffersen AC, Haugan A, Janakova L, Korsvold GE, Krogh G, Andersen EA, Djupesland P, Holand T, Rappuoli R, Haneberg B.

Scand J Immunol. 2006 Mar;63(3):223-31.

PMID:
16499576
[PubMed - indexed for MEDLINE]
14.

Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.

Muhamed G, Greenbaum E, Zakay-Rones Z.

Isr Med Assoc J. 2006 Mar;8(3):155-8.

PMID:
16599048
[PubMed - indexed for MEDLINE]
Free Article
15.

[Development of mucosal influenza inactivated vaccines].

Gendon IuZ.

Zh Mikrobiol Epidemiol Immunobiol. 2003 Jul-Aug;(4):110-7. Review. Russian.

PMID:
12966895
[PubMed - indexed for MEDLINE]
16.

Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.

Greenbaum E, Engelhard D, Levy R, Schlezinger M, Morag A, Zakay-Rones Z.

Vaccine. 2004 Jun 30;22(20):2566-77.

PMID:
15193382
[PubMed - indexed for MEDLINE]
17.

A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats.

Huang J, Garmise RJ, Crowder TM, Mar K, Hwang CR, Hickey AJ, Mikszta JA, Sullivan VJ.

Vaccine. 2004 Dec 21;23(6):794-801.

PMID:
15542204
[PubMed - indexed for MEDLINE]
18.

Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.

Ichinohe T, Watanabe I, Tao E, Ito S, Kawaguchi A, Tamura S, Takahashi H, Sawa H, Moriyama M, Chiba J, Komase K, Suzuki Y, Kurata T, Sata T, Hasegawa H.

J Med Virol. 2006 Jul;78(7):954-63.

PMID:
16721854
[PubMed - indexed for MEDLINE]
19.

Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses.

Kamijuku H, Nagata Y, Jiang X, Ichinohe T, Tashiro T, Mori K, Taniguchi M, Hase K, Ohno H, Shimaoka T, Yonehara S, Odagiri T, Tashiro M, Sata T, Hasegawa H, Seino KI.

Mucosal Immunol. 2008 May;1(3):208-18. doi: 10.1038/mi.2008.2. Epub 2008 Mar 5.

PMID:
19079180
[PubMed - indexed for MEDLINE]
20.

Improved design and intranasal delivery of an M2e-based human influenza A vaccine.

De Filette M, Fiers W, Martens W, Birkett A, Ramne A, Löwenadler B, Lycke N, Jou WM, Saelens X.

Vaccine. 2006 Nov 10;24(44-46):6597-601. Epub 2006 Jun 12.

PMID:
16814430
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk